Inactive Instrument
Albany Molecular Research, Inc. Stock
Stocks
US0124231095
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Macnabb
CEO | Chief Executive Officer | - | 01/03/2023 |
Gerald Auer
DFI | Director of Finance/CFO | - | 01/01/2024 |
Gregg Kuzma
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.09% | - | - | 0 | ||
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | ||
| +1.76% | +2.10% | +12.10% | +81.21% | 54.55B | ||
| -0.94% | +0.99% | +10.45% | +102.18% | 53.59B | ||
| +2.76% | +0.87% | +27.92% | +57.51% | 44.75B | ||
| +2.00% | -3.39% | +17.83% | +100.08% | 41.62B | ||
| +1.34% | -2.86% | +224.43% | +928.45% | 39.91B | ||
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | ||
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | ||
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | ||
| Average | +4.08% | -0.42% | +52.15% | +162.98% | 42.27B | |
| Weighted average by Cap. | +3.21% | -0.29% | +47.59% | +161.58% |
















